TET loss of function selects for aneuploidies that confer a proliferative advantage

Abstract Mutations in the Ten-Eleven Translocation (TET) family of DNA dioxygenases are among the most common epigenetic alterations in clonal hematopoiesis and hematologic malignancies, yet how TET loss of function reshapes genome evolution during cellular expansion remains to be fully understood. Here we show that loss of Tet2/3 in invariant natural killer T (iNKT) cells drives aggressive lymphoid expansion that is consistently associated with recurrent chromosome 17 trisomy, a dominant aneuploid state observed across more than ten independently derived tumors following transplantation into immunocompetent recipient mice. Single-cell whole-genome sequencing of TET-deficient iNKT cells induced to proliferate in culture with antigen and IL-2 stimulation revealed that rare pre-existing cells with chromosome 17 trisomy appeared soon after Tet gene deletion in the thymus, together with cells harboring other copy number alterations, but only the cells with chromosome 17 trisomy were progressively enriched during further expansion. Similarly, inducibly Tet -deficient mouse embryonic stem cells (mESCs) showed selection for aneuploid states that were present prior to Tet gene deletion, including trisomy of chromosome 6. Reanalysis of independent datasets from Dnmt3a -deficient mouse lymphomas identified recurrent chromosome gains, including chromosome 17 trisomy. Our results establish TET and DNMT3A deficiency as drivers of karyotypic evolution, and suggest that disruption of DNA methylation/ demethylation pathways through either TET or DNMT3A deletion promotes chromosomal instability, in part by facilitating the emergence and selection of cryptic aneuploid subclones during clonal expansion.